Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
2020 ◽
Vol 34
(3)
◽
pp. 381-393
Jinmei Su
◽
Mengtao Li
◽
Lan He
◽
Dongbao Zhao
◽
Weiguo Wan
◽
...
2012 ◽
Vol 13
(3)
◽
pp. 191-197
◽
Vesile Öztürk
◽
Mustafa Ertaş
◽
Betül Baykan
◽
Hadiye Şirin
◽
Aynur Özge
◽
...
2020 ◽
Vol 42
(12)
◽
pp. 2266-2279
Min-Kyung Lee
◽
Younghoon Jeon
◽
Sang Sik Choi
◽
Pyung Bok Lee
◽
Yong-Chul Kim
◽
...
2020 ◽
Vol 105
◽
pp. 106962
◽
Fenella Kirkham
◽
Stéphane Auvin
◽
Joana Moreira
◽
Helena Gama
◽
Amílcar C. Falcão
◽
...
Joo Han Lim
◽
Ki-Hyeong Lee
◽
Keon-Uk Park
◽
In-Hae Park
◽
Eun Kyung Cho
◽
...
Myung-Ku Kim
◽
Chul-Won Ha
◽
Yong In
◽
Sung-Do Cho
◽
Eui-Sung Choi
◽
...
2020 ◽
Vol 101
(9)
◽
pp. 1485-1496
Junekyung Lee
◽
Min Ho Chun
◽
Young Jin Ko
◽
Shi-Uk Lee
◽
Deog Young Kim
◽
...
2018 ◽
Vol 29
(1)
◽
pp. 48-59
◽
Myung-Ku Kim
◽
Chul-Won Ha
◽
Yong In
◽
Sung-Do Cho
◽
Eui-Sung Choi
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14679-14679
J Brandt
◽
R Alten
◽
G Burmester
◽
E Gromnica-Ihle
◽
H Kellner
◽
...
2018 ◽
Vol 14
(5)
◽
pp. e310-e316
◽
Jia Chen
◽
Jianping Xiong
◽
Jiejun Wang
◽
Leizhen Zheng
◽
YanFei Gao
◽
...
Close
Export Citation Format
Close
Share Document
Close